SIL Investments consolidated PAT up 151% YoY to ₹20.5 Cr on stronger portfolio gains

SIL Investments, an RBI-registered 'Middle Layer' NBFC whose sole reportable segment is investment and financing activities, reported consolidated total income of ₹23.75 Cr and PAT of ₹20.54 Cr (owner's share ₹20.22 Cr, NCI ₹0.32 Cr) for Q1 FY27, up roughly 72% and 151% YoY from ₹13.67 Cr revenue and ₹8.19 Cr PAT a year ago. Standalone PAT was ₹12.47 Cr against ₹4.80 Cr YoY (EPS ₹11.77), broadly tracking the consolidated growth rate — standalone and consolidated tell a consistent story this quarter, no material divergence. No brokerage previews or consensus estimates for this micro-cap NBFC turned up in a web search, so vsStreet is unknown; the company also carries no formal earnings guidance on record, so the print cannot be benchmarked against a prior management outlook either.

The growth was driven almost entirely by 'net gain on fair value changes' — mark-to-market gains on the company's equity/investment book — which rose to ₹19.41 Cr consolidated (₹10.69 Cr standalone) from ₹8.13 Cr (₹4.88 Cr standalone) a year ago, while interest and dividend income were roughly flat and total expenses actually fell slightly YoY (₹2.92 Cr vs ₹3.18 Cr consolidated). That combination pushed consolidated net profit margin to about 86.5% of total income from 59.9% a year ago. Because this line is volatile, Q4FY26 (quarter to 31 March 2026) saw a fair-value LOSS that dragged both revenue from operations (-₹5.64 Cr) and consolidated PAT (-₹9.46 Cr) negative — so this quarter's headline growth is as much a reversal of that mark-to-market swing as organic growth, and a QoQ read off that loss base is not meaningful.

The stock went into the print at ₹435, up 3.1% over the past month of trading.

For context: this is the highest quarterly PAT in the last 6 quarters on our records.

Basic & diluted EPS ₹19.09 for the quarter, vs ₹7.47 a year ago and -₹8.59 in Q4FY26.

No management press release accompanied the filing beyond the standard board-outcome letter, so there is no separate management commentary to reconcile against the numbers. The quarter's other corporate developments — the 92nd AGM held 31 July 2026, the FY26 annual report, and a dividend with 24 July 2026 record date — are routine and don't bear directly on this quarter's P&L. The results are un-audited with only a limited review (SRE 2410); auditors for both statements flagged, as a standard 'Other Matter', that the Q4FY26 comparative figures are balancing figures rather than independently reported numbers, and the consolidated auditor relied on other auditors'/management-certified figures for two India step-down subsidiaries and the Singapore subsidiary.